Skip to content

Released Aug 10, 2023, before the open

10-Q filed Aug 11, 2023, 42 days after period end · 0000868278-23-000014

Q2 2023 · 10-Q
Revenue$13.22M−54.6% vs Q2 2022−31.5% vs Q1 2023
Net Income-$3.44MN/M vs Q2 2022N/M vs Q1 2023
EPS Diluted-$0.20N/M vs Q2 2022N/M vs Q1 2023
Gross Profit$6,448,000−65.6%
Operating Income-$4,658,000N/M
Operating Cash Flowderived-$6,957,000N/M
Free Cash Flowderived-$7,617,000N/M
Margins · derived
Gross margin48.8%−15.6 pt vs Q2 2022
Operating margin-35.2%−71.6 pt vs Q2 2022
Net margin-26.0%−51.6 pt vs Q2 2022

What the release said

The release

Same quarter

MetricQ2 2023Q2 2022Q2 2021Q2 2020
Revenue$13.22M$29.09M$9.14M$3.62M
Net Income-$3.44M$7.45M-$1.40M$70.00K
EPS Diluted-$0.20$0.40-$0.09$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR